News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,569 Results
Type
Article (88836)
Company Profile (816)
Press Release (794895)
Multimedia
Podcasts (240)
Webinars (35)
Section
Business (233617)
Career Advice (4163)
Deals (40001)
Drug Delivery (179)
Drug Development (91735)
Employer Resources (207)
FDA (18565)
Job Trends (17490)
News (398789)
Policy (40018)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3055)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (208)
Alliances (56990)
ALS (239)
Alzheimer's disease (1983)
Antibody-drug conjugate (ADC) (564)
Approvals (18927)
Artificial intelligence (893)
ASCO (345)
Autoimmune disease (366)
Automation (66)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (249)
Biotechnology (480)
Bladder cancer (212)
Brain cancer (85)
Breast cancer (842)
Cancer (6659)
Cardiovascular disease (561)
Career advice (3599)
Career pathing (52)
CAR-T (388)
CDC (77)
Celiac Disease (3)
Cell therapy (1083)
Cervical cancer (56)
Clinical research (79158)
Collaboration (2403)
Commercialization (1)
Company closure (8)
Compensation (1541)
Complete response letters (107)
COVID-19 (3043)
CRISPR (126)
C-suite (1309)
Cystic fibrosis (168)
Data (8815)
Decentralized trials (3)
Denatured (92)
Depression (199)
Dermatology (97)
Diabetes (714)
Diagnostics (7615)
Digital health (71)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (443)
Drug pricing (247)
Drug shortages (39)
Duchenne muscular dystrophy (320)
Earnings (102507)
Editorial (80)
Employer branding (25)
Employer resources (174)
Events (138816)
Executive appointments (1203)
FDA (22700)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1977)
Gene editing (274)
Generative AI (91)
Gene therapy (859)
GLP-1 (1288)
Government (5564)
Grass and pollen (8)
Guidances (421)
Healthcare (21267)
Hematology (198)
HIV (98)
Huntington's disease (67)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (360)
Immuno-oncology (116)
Indications (214)
Infectious disease (3450)
Inflammatory bowel disease (244)
Inflation Reduction Act (17)
Influenza (153)
Intellectual property (327)
Interviews (822)
IPO (18007)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (23)
Labor market (125)
Layoffs (690)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (879)
Lymphoma (481)
Machine learning (69)
Management (66)
Manufacturing (1256)
Marketing (1)
MASH (228)
Medical affairs (1)
Medical device (15288)
Medtech (15460)
Mergers & acquisitions (23312)
Metabolic disorders (1843)
mRNA (273)
Multiple sclerosis (208)
NASH (24)
Neurodegenerative disease (518)
Neuropsychiatric disorders (130)
Neuroscience (3762)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5147)
Now hiring (82)
Obesity (876)
Opinion (375)
Ovarian cancer (246)
Pain (287)
Pancreatic cancer (364)
Parkinson's disease (422)
Partnered (41)
Patents (666)
Patient recruitment (776)
Peanut (71)
People (68065)
Pharmaceutical (136)
Pharmacy benefit managers (38)
Phase 1 (24463)
Phase 2 (34391)
Phase 3 (25853)
Pipeline (9958)
Policy (401)
Postmarket research (3560)
Preclinical (10995)
Press Release (72)
Prostate cancer (353)
Psychedelics (73)
Radiopharmaceuticals (375)
Rare diseases (1286)
Real estate (7462)
Recruiting (81)
Regulatory (30481)
Reports (77)
Research institute (2773)
Resumes & cover letters (654)
Rett syndrome (44)
RNA editing (30)
RSV (100)
Schizophrenia (197)
Series A (338)
Series B (244)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4373)
State (2)
Stomach cancer (21)
Supply chain (149)
Tariffs (104)
The Weekly (145)
Vaccines (1317)
Venture capital (138)
Weight loss (600)
Women's health (144)
Worklife (24)
Date
Today (120)
Last 7 days (499)
Last 30 days (2765)
Last 365 days (33240)
2026 (16932)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (407)
Arkansas (16)
Asia (52354)
Australia (9201)
California (14504)
Canada (4048)
China (1601)
Colorado (624)
Connecticut (645)
Delaware (450)
Europe (120729)
Florida (2164)
Georgia (470)
Hawaii (4)
Idaho (70)
Illinois (1267)
India (105)
Indiana (671)
Iowa (26)
Japan (610)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1754)
Massachusetts (10626)
Michigan (427)
Minnesota (807)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (92)
New Jersey (3847)
New Mexico (35)
New York (3817)
North Carolina (1951)
North Dakota (11)
Northern California (7215)
Ohio (454)
Oklahoma (27)
Oregon (55)
Pennsylvania (2849)
Puerto Rico (33)
Rhode Island (55)
South America (1668)
South Carolina (89)
South Dakota (2)
Southern California (5697)
Tennessee (233)
Texas (2370)
United States (51920)
Utah (433)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1192)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,569 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
BIO 2026: US public health as we know it is gone. Can we rebuild a better system?
Former FDA, CDC and NIH leaders convene at the BIO International Convention to discuss the dismantling of the Department of Health and Human Services under the Trump administration—and where we go from here.
June 23, 2026
·
4 min read
·
Jef Akst
Manufacturing
With onshoring ‘having a moment,’ Aquestive CEO shares lessons from 20 years of US manufacturing
Having stuck with local production in the years when offshoring to lower-cost locations was in fashion, Aquestive’s CEO is well placed to explain what the recent reshoring drive means for manufacturers.
June 23, 2026
·
4 min read
·
Nick Paul Taylor
Press Releases
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
June 23, 2026
·
9 min read
Press Releases
CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study
June 23, 2026
·
4 min read
Press Releases
AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
June 23, 2026
·
9 min read
Press Releases
Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer
June 23, 2026
·
5 min read
Press Releases
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
June 23, 2026
·
11 min read
Press Releases
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
June 23, 2026
·
10 min read
Press Releases
Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission
June 23, 2026
·
3 min read
Press Releases
Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
June 23, 2026
·
9 min read
1 of 88,457
Next
